IJCS | Volume 31, Nº6, November / December 2018

583 1. Barbosa PJB, Muller RE, Braga ALL, Achutti AC, Ramos AIO, Weksler C, et al. Diretrizes brasileiras para o diagnóstico, tratamento e prevenção da febre reumática da Sociedade Brasileira de Cardiologia, Sociedade Brasileira de Pediatria e Sociedade Brasileira de Reumatologia. Arq Bras Cardiol. 2009; 93 (3 supl. 4): 1-18. 2. World Health Organization (WHO). Rheumatic fever and rheumatic heart disease: report of a WHO expert consultation on rheumatic fever and rheumatic heart disease. Geneva; 2004. 3. Bisno AL, Gerber MA, Gwaltney JM Jr, Kaplan EL, Schwartz RH; Infectious Diseases Society of America. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Clin Infect Dis. 2002;35(2):113-25. 4. Instituto Brasileiro de Geografia e Estatística. (IBGE) [Internet]. Censo: informações de saúde. [Acesso em 2016 Dez 3]. Disponível em: http:// www.ibge.gov.br. 5. Brasil. Ministério da Saúde. Instituto Nacional de Cardiologia. Relatório de gestão. [Acesso em 2016 Dez 18]. Disponível em: http://www.incl . rj.saude.gov.br/htm/inc.htm. 6. Muller RE. Estudo longitudinal de pacientes portadores de cardiopatia reumática no Rio de Janeiro [Dissertação]. Rio de Janeiro: Ministério da Saúde/FIOCRUZ; 2008. 7. Brasil. Ministério da Saúde. InstitutoNacional de Cardiologia. Programas e Corporações. [Acesso em 2016 Dez 20]. Disponível em: http://www. inc.saude.gov.br/htm/programas.htm. 8. Brasil. Ministério da Saúde. Sistema de Informações Hospitalares do SUS (SIH/SUS). [Acesso em 2016 Dez 9]. Disponível em: http://w3.datasus . gov.br/datasus/datasus.php. 9. Herdy GVH. The challenge of secondary prophylaxis in rheumatic fever. Arq Bras Cardiol. 1996;67(5):317. 10. Brasil. Ministério da Saúde. Portaria nº. 156 de 20 de janeiro de 2006. Dispõe sobre o uso da penicilina na atenção básica à saúde e nas demais unidades do Sistema Único de Saúde (SUS). [Acesso em 2016 Dez 22]. Disponível em: http://www.aids.gov.br/sites/default/files/anexos/ legislacao/2006/52649/portaria_156_2006_24885.pdf. 11. Guidelines for the diagnosis of rheumatic fever: Jones Criteria, 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease on the Council of Cardiovascular Disease in the Young of the American Heart Association. JAMA. 1992;268(15):2069-73. 12. Gerber MA, Baltimore RS, Eaton CB, Gewitz M, Rowley AH, Shulman ST, et al; American Academy of Pediatrics. Prevention of rheumatic fever and diagnosis and treatment of acute streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research. Circulation. 2009;119(11):1541-51. 13. Beggs S, Peterson G, Tompson A. Antibiotic use for the prevention and treatment of rheumatic fever and rheumatic heart disease in children. Report for the 2nd Meeting of World Health Organization’s subcommittee of the Expert Committee of the Selection and Use of Essential Medicines. 2008 Oct 29-Sept 3; Geneva: WHO; 2008. 14. Camara EJ, Braga JC, Alves-Silva LS, Camara GF, da Silva Lopes AA. Comparison of an intravenous pulse of methylprednisolone versus oral corticosteroid in severe acute rheumatic carditis: a randomized clinical trial. Cardiol Young. 2002;12(2):119-24. 15. Herdy GV, Pinto CA, Olivaes MC, Carvalho EA, Tchou H, Cosendey R, et al. Rheumatic carditis treated with high doses of pulsetherapy methylprednisolone. Results in 70 children over 12 years. Arq Bras Cardiol. 1999;72(5):601-6. 16. Saxena A, Kumar RK, Gera RP, Radhakrishnan S, Mishra S, Ahmed Z. Consensus guidelines on pediatric acute rheumatic fever and rheumatic heart disease. Indian Pediatr. 2008;45(7):565-73. 17. Manyemba J, Mayosi BM. Penicillin for secondary prevention of rheumatic fever. Cochrane Database Syst Rev.2002;3: CD002227. 18. Febrônio MV, Sousa RO. Febre reumática. In: Da Silva CAA. Doenças reumáticas na criança e no adolescente. São Paulo: Manole; 2008. p. 70-97. References Lemos et al. Evolutive study of rheumatic carditis cases Int J Cardiovasc Sci. 2018;31(6)578-584 Original Article treatment proved to be effective, decreasing damage in the three valves. Author contributions Conception and design of the research: Lemos FMCF, Herdy GVH, Valete COS, Pfeiffer MET. Acquisition of data: Lemos FMCF. Analysis and interpretationof the data: Lemos FMCF, Herdy GVH, Valete COS, Pfeiffer MET. Statistical analysis: Valete COS.Writing of themanuscript: Lemos FMCF, Herdy GVH, Valete COS, Pfeiffer MET. Critical revision of themanuscript for intellectual content: Lemos FMCF, Herdy GVH, Valete COS, Pfeiffer MET. Potential Conflicts of Interest No potential conflicts of interest relevant to this article were reported. Sources of Funding There were no external funding sources for this study. Study Association This article is part of the Master’s degree thesis submitted by Fernanda Maria Correia Ferreira Lemos to Universidade Federal Fluminense. Ethics approval and consent to participate This study was approved by the Ethics Committee of the Instituto Estadual de Cardiologia Aloysio de Castro under the protocol number 21608213.0.0000.5265. All the procedures in this study were in accordance with the 1975 Helsinki Declaration, updated in 2013. As a retrospective study, there was no need to obtain the Free and Informed Consent form.